These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23451879)

  • 1. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report.
    Jacquot C; Moayeri M; Kim B; Shugarts S; Lynch KL; Leavitt AD
    Transfusion; 2013 Nov; 53(11):2715-21. PubMed ID: 23451879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flucloxacillin-induced immune thrombocytopenia.
    Jatzlauk G; Althaus K; Strobel U; Kiefel V; Wesche J; Muehlenberg K; Greinacher A; Bakchoul T
    Transfusion; 2016 Jan; 56(1):67-72. PubMed ID: 26331798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of transfusion of platelet antibody: a case report and literature review.
    Pavenski K; Webert KE; Goldman M
    Transfusion; 2008 Sep; 48(9):1981-9. PubMed ID: 18564398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature.
    Plakogiannis R; Nogid A
    Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody.
    Ruggero MA; Abdelghany O; Topal JE
    Pharmacotherapy; 2012 Nov; 32(11):e321-5. PubMed ID: 23065779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem-induced immune thrombocytopenia and the diagnostic process of laboratory testing.
    Huang R; Cai GQ; Zhang JH; Liu FX; Ma JQ; Liu H; Nie XM; Gui R
    Transfusion; 2017 Nov; 57(11):2715-2719. PubMed ID: 28782250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-mediated pancytopenia induced by oxaliplatin: a case report.
    Fontão-Wendel R; Hoff PM; Lazar A; Freitas D; Novis Y; Patah P; Tsujita M; Balthazar A; Pierroti M; Wendel S
    Transfusion; 2010 Jul; 50(7):1453-9. PubMed ID: 20210930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
    Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
    Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved mouse models for the study of treatment modalities for immune-mediated platelet destruction.
    Katsman Y; Foo AH; Leontyev D; Branch DR
    Transfusion; 2010 Jun; 50(6):1285-94. PubMed ID: 20088841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 7-year case of furosemide-induced immune thrombocytopenia.
    Ochoa PS; Fisher T
    Pharmacotherapy; 2013 Jul; 33(7):e162-5. PubMed ID: 23625769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of pseudothrombocytopenia during antibiotic administration].
    Kinoshita Y; Yamane T; Kamimoto A; Oku H; Iwata Y; Kobayashi T; Hino M
    Rinsho Byori; 2004 Feb; 52(2):120-3. PubMed ID: 15027315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfamethoxazole-induced thrombocytopenia masquerading as posttransfusion purpura: a case report.
    Nixon CP; Cheves TA; Sweeney JD
    Transfusion; 2015 Nov; 55(11):2738-41. PubMed ID: 26098194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin-Tazobactam-Induced Immune Thrombocytopenia: A Case Report.
    Kiliaki S
    J Pharm Pract; 2023 Apr; 36(2):451-452. PubMed ID: 34558345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute vancomycin-dependent immune thrombocytopenia as an anamnestic response.
    Kenney B; Tormey CA
    Platelets; 2008 Aug; 19(5):379-83. PubMed ID: 18791945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.
    Thomas-Kaskel AK; Mattern D; Köhler G; Finke J; Behringer D
    Cytometry B Clin Cytom; 2007 Jul; 72(4):241-8. PubMed ID: 17266149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in the diagnosis of immune thrombocytopenic purpura in children: 4 case reports.
    Biner B; Devecioğlu O; Demir M
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):329-33. PubMed ID: 17636197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating thrombotic microangiopathies induced by severe hypertension from anemia and thrombocytopenia seen in thrombotic thrombocytopenia purpura.
    Egan JA; Bandarenko N; Hay SN; Paradowski L; Goldberg R; Nickeleit V; Brecher ME
    J Clin Apher; 2004; 19(3):125-9. PubMed ID: 15493050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
    Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.